Correlation Between DiaMedica Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on DiaMedica Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for DiaMedica Therapeutics and SAB Biotherapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between DiaMedica and SAB is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 33.42 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, DiaMedica Therapeutics is 22.93 times less risky than SAB Biotherapeutics. It trades about 0.08 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 5.40 in SAB Biotherapeutics on August 26, 2024 and sell it today you would earn a total of 1.90 from holding SAB Biotherapeutics or generate 35.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 75.45% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. SAB Biotherapeutics
Performance |
| Timeline |
| DiaMedica Therapeutics |
| SAB Biotherapeutics |
DiaMedica Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite DiaMedica Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals | SAB Biotherapeutics vs. Surrozen Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |